 |
| ||
| Join/Renew Contact ONS Terms of Use FAQ | |||
| HOME |  |
CNE Central | |
Clinical Practice | |
Membership | |
Patient Education | |
Publications | |
Research |
| About ONS |
| Shop, Join, Register |
| Career Center |
| Legislative Action Area |
| Global Affairs |
| Oncology News |
| Awards, Grants, Scholarships |
| Commercial Support |
| Media Center |
| From the Editor |
|
ONS Profile |
Oncology News
New Cancer Drug Approvals/FDA Updates
In collaboration with the Food and Drug Administration, ONS provides its members with information about newly approved therapies for
patients with cancer via email. When such a communication is issued, ONS will immediately send an email indicating the nature of the
communication and provide a link to the full text of the communication. This will include information from the product label to
provide relevant clinical information on the indication, contraindications, dosing, and safety. Below is a list of all current
communications. ONS also maintains an archive of past communications, please click here to access
this archive.
| Date Sent | Manufacturer | Drug | Additional Information |
| March 20, 2008 | Cephalon, Inc. | TREANDA® | |
| February 22, 2008 | Genentech, Inc. | Avastin® | |
| November 16, 2007 | Bayer Pharmaceuticals Corporation and Onyx Pharmaceuticals, Inc | NEXAVAR® | |
| November 8, 2007 | n/a | n/a | FDA Approved Boxed Warnings and other safety-related product labeling changes for the erythropoiesis-stimulating agents Epogen, Procrit, and Aranesp. |
| November 8, 2007 | Bristol-Myers Squibb | SPRYCEL™ | |
| October 29, 2007 | Novartis Pharmaceuticals Corp. | Tasigna® Capsules | |
| October 16, 2007 | Bristol-Myers Squibb | IXEMPRA™ | FDA approved ixabepilone injection for two indications |
| October 2, 2007 | ImClone Systems, Inc. | Erbitux® | Expanded labeling and granted regular approval |
| September 28, 2007 | Sanofi-Aventis | Taxotere® Injection Concentrate | |
| September 19, 2007 | Genzyme Corporation | Campath® | FDA expanded labeling and granted regular approval for single-agent alemtuzumab |
| September 17, 2007 | Genentech, Inc. | Avastin® | Warning and Dose and Administration for Non-Gastrointestinal Fistula Formation |
| September 13, 2007 | Lilly and Company | EVISTA® | |
| September 6, 2007 | TopoTarget | Totect™ |
If you are a member of ONS, and are not receiving these messages, you can adjust your email preferences by logging into your profile at https://profile.ons.org and then selecting "Preferences." If you do not have a profile, create one now.
Links
Overwhelmed by the amount of cancer news on the Internet? Try these links. The ONS website Editorial Board has reviewed them and found them to have excellent functionality and credibility.
Cancer News
Provided by CancerSource
Cancer Statistics 2006
Provided by the American Cancer Society
Cancer Treatment News
Provided by CancerConsultants.com
Major News Releases
Provided by the National Cancer Institute
Oncology Calendar
From continuing education programming to dates and deadlines related to certification, awards, grants, scholarships, and more, you'll find it all on this easy-to-use calendar.